{"id":"https://openalex.org/W1967676836","doi":"https://doi.org/10.1111/gtc.12022","title":"Activity\u2010based kinase profiling of approved tyrosine kinase inhibitors","display_name":"Activity\u2010based kinase profiling of approved tyrosine kinase inhibitors","alternate_titles":[],"publication_year":2012,"publication_date":"2012-12-26","ids":{"openalex":"https://openalex.org/W1967676836","doi":"https://doi.org/10.1111/gtc.12022","mag":"1967676836","pmid":"https://pubmed.ncbi.nlm.nih.gov/23279183"},"language":"en","primary_location":{"id":"doi:10.1111/gtc.12022","doi":"https://doi.org/10.1111/gtc.12022","is_oa":false,"landing_page_url":"https://doi.org/10.1111/gtc.12022","pdf_url":null,"source":{"id":"https://openalex.org/S48908450","display_name":"Genes to Cells","issn_l":"1356-9597","issn":["1356-9597","1365-2443"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Genes to Cells","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1967676836"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015567690","display_name":"Daisuke Kitagawa","orcid":"https://orcid.org/0000-0002-1850-9337","observed_orcids":["https://orcid.org/0000-0002-1850-9337"]},"institutions":[{"id":"https://openalex.org/I4405285453","display_name":"Carna Biosciences (Japan)","ror":"https://ror.org/05fw9gc86","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405285453"]}],"countries":["JP"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Daisuke Kitagawa","raw_affiliation_strings":["Carna Biosciences, Inc. 3rd Floor, BMA, 1\u20105\u20105, Minatojima\u2010Minamimachi Chuo\u2010ku Kobe 650\u20100047 Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carna Biosciences, Inc. 3rd Floor, BMA, 1\u20105\u20105, Minatojima\u2010Minamimachi Chuo\u2010ku Kobe 650\u20100047 Japan","institution_ids":["https://openalex.org/I4405285453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113882127","display_name":"Koichi Yokota","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405285453","display_name":"Carna Biosciences (Japan)","ror":"https://ror.org/05fw9gc86","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405285453"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Koichi Yokota","raw_affiliation_strings":["Carna Biosciences, Inc. 3rd Floor, BMA, 1\u20105\u20105, Minatojima\u2010Minamimachi Chuo\u2010ku Kobe 650\u20100047 Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carna Biosciences, Inc. 3rd Floor, BMA, 1\u20105\u20105, Minatojima\u2010Minamimachi Chuo\u2010ku Kobe 650\u20100047 Japan","institution_ids":["https://openalex.org/I4405285453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051818672","display_name":"Masaki Gouda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405285453","display_name":"Carna Biosciences (Japan)","ror":"https://ror.org/05fw9gc86","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405285453"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Masaki Gouda","raw_affiliation_strings":["Carna Biosciences, Inc. 3rd Floor, BMA, 1\u20105\u20105, Minatojima\u2010Minamimachi Chuo\u2010ku Kobe 650\u20100047 Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carna Biosciences, Inc. 3rd Floor, BMA, 1\u20105\u20105, Minatojima\u2010Minamimachi Chuo\u2010ku Kobe 650\u20100047 Japan","institution_ids":["https://openalex.org/I4405285453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047758405","display_name":"Yugo Narumi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405285453","display_name":"Carna Biosciences (Japan)","ror":"https://ror.org/05fw9gc86","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405285453"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yugo Narumi","raw_affiliation_strings":["Carna Biosciences, Inc. 3rd Floor, BMA, 1\u20105\u20105, Minatojima\u2010Minamimachi Chuo\u2010ku Kobe 650\u20100047 Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carna Biosciences, Inc. 3rd Floor, BMA, 1\u20105\u20105, Minatojima\u2010Minamimachi Chuo\u2010ku Kobe 650\u20100047 Japan","institution_ids":["https://openalex.org/I4405285453"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Hiroshi Ohmoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405285453","display_name":"Carna Biosciences (Japan)","ror":"https://ror.org/05fw9gc86","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405285453"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hiroshi Ohmoto","raw_affiliation_strings":["Carna Biosciences, Inc. 3rd Floor, BMA, 1\u20105\u20105, Minatojima\u2010Minamimachi Chuo\u2010ku Kobe 650\u20100047 Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carna Biosciences, Inc. 3rd Floor, BMA, 1\u20105\u20105, Minatojima\u2010Minamimachi Chuo\u2010ku Kobe 650\u20100047 Japan","institution_ids":["https://openalex.org/I4405285453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112006754","display_name":"Eiji Nishiwaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405285453","display_name":"Carna Biosciences (Japan)","ror":"https://ror.org/05fw9gc86","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405285453"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Eiji Nishiwaki","raw_affiliation_strings":["Carna Biosciences, Inc. 3rd Floor, BMA, 1\u20105\u20105, Minatojima\u2010Minamimachi Chuo\u2010ku Kobe 650\u20100047 Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carna Biosciences, Inc. 3rd Floor, BMA, 1\u20105\u20105, Minatojima\u2010Minamimachi Chuo\u2010ku Kobe 650\u20100047 Japan","institution_ids":["https://openalex.org/I4405285453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071672458","display_name":"Kensaku Akita","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405285453","display_name":"Carna Biosciences (Japan)","ror":"https://ror.org/05fw9gc86","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405285453"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kensaku Akita","raw_affiliation_strings":["Carna Biosciences, Inc. 3rd Floor, BMA, 1\u20105\u20105, Minatojima\u2010Minamimachi Chuo\u2010ku Kobe 650\u20100047 Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carna Biosciences, Inc. 3rd Floor, BMA, 1\u20105\u20105, Minatojima\u2010Minamimachi Chuo\u2010ku Kobe 650\u20100047 Japan","institution_ids":["https://openalex.org/I4405285453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5016963729","display_name":"Yasuyuki Kirii","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405285453","display_name":"Carna Biosciences (Japan)","ror":"https://ror.org/05fw9gc86","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405285453"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yasuyuki Kirii","raw_affiliation_strings":["Carna Biosciences, Inc. 3rd Floor, BMA, 1\u20105\u20105, Minatojima\u2010Minamimachi Chuo\u2010ku Kobe 650\u20100047 Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carna Biosciences, Inc. 3rd Floor, BMA, 1\u20105\u20105, Minatojima\u2010Minamimachi Chuo\u2010ku Kobe 650\u20100047 Japan","institution_ids":["https://openalex.org/I4405285453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5015567690"],"corresponding_institution_ids":["https://openalex.org/I4405285453"],"apc_list":{"value":3800,"currency":"USD","value_usd":3800},"apc_paid":null,"fwci":5.9241,"has_fulltext":false,"cited_by_count":221,"citation_normalized_percentile":{"value":0.97795106,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"18","issue":"2","first_page":"110","last_page":"122"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.5181000232696533,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.5181000232696533,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.2483000010251999,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.07090000063180923,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.9869999885559082},{"id":"https://openalex.org/keywords/imatinib","display_name":"imatinib","score":0.7179999947547913},{"id":"https://openalex.org/keywords/dasatinib","display_name":"dasatinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/nilotinib","display_name":"nilotinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/gefitinib","display_name":"gefitinib","score":0.9980000257492065},{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":1.0},{"id":"https://openalex.org/keywords/lapatinib","display_name":"lapatinib","score":1.0},{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":1.0},{"id":"https://openalex.org/keywords/sunitinib","display_name":"sunitinib","score":1.0},{"id":"https://openalex.org/keywords/pazopanib","display_name":"pazopanib","score":1.0},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.7279999852180481},{"id":"https://openalex.org/keywords/atp-concentration-dependence","display_name":"ATP concentration dependence","score":0.4560000002384186}],"concepts":[{"id":"https://openalex.org/C2779536868","wikidata":"https://www.wikidata.org/wiki/Q419940","display_name":"Dasatinib","level":4,"score":0.7092368602752686},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.7035055160522461},{"id":"https://openalex.org/C2777329042","wikidata":"https://www.wikidata.org/wiki/Q420323","display_name":"Lapatinib","level":5,"score":0.6867532134056091},{"id":"https://openalex.org/C2779490328","wikidata":"https://www.wikidata.org/wiki/Q417542","display_name":"Sunitinib","level":3,"score":0.6371864080429077},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.6331984996795654},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.5264977812767029},{"id":"https://openalex.org/C2777413986","wikidata":"https://www.wikidata.org/wiki/Q412327","display_name":"Nilotinib","level":4,"score":0.515214741230011},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4990055561065674},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4465239346027374},{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.4239032566547394},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3385149836540222},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.23849356174468994},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.15638059377670288},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.06212058663368225},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.0},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000255","descriptor_name":"Adenosine Triphosphate","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004789","descriptor_name":"Enzyme Activation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010802","descriptor_name":"Phylogeny","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011494","descriptor_name":"Protein Kinases","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D011494","descriptor_name":"Protein Kinases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011494","descriptor_name":"Protein Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D015203","descriptor_name":"Reproducibility of Results","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020128","descriptor_name":"Inhibitory Concentration 50","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020543","descriptor_name":"Proteome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D020869","descriptor_name":"Gene Expression Profiling","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/gtc.12022","doi":"https://doi.org/10.1111/gtc.12022","is_oa":false,"landing_page_url":"https://doi.org/10.1111/gtc.12022","pdf_url":null,"source":{"id":"https://openalex.org/S48908450","display_name":"Genes to Cells","issn_l":"1356-9597","issn":["1356-9597","1365-2443"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Genes to Cells","raw_type":"journal-article"},{"id":"pmid:23279183","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23279183","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Genes to cells : devoted to molecular & cellular mechanisms","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":59,"referenced_works":["https://openalex.org/W1538925875","https://openalex.org/W1569559112","https://openalex.org/W1977128714","https://openalex.org/W2000624583","https://openalex.org/W2000991161","https://openalex.org/W2001097406","https://openalex.org/W2003973314","https://openalex.org/W2011588737","https://openalex.org/W2014582878","https://openalex.org/W2016475117","https://openalex.org/W2018348203","https://openalex.org/W2024403886","https://openalex.org/W2026542427","https://openalex.org/W2030205108","https://openalex.org/W2040022677","https://openalex.org/W2044254728","https://openalex.org/W2045194073","https://openalex.org/W2046822015","https://openalex.org/W2052750950","https://openalex.org/W2054251966","https://openalex.org/W2055018478","https://openalex.org/W2055726227","https://openalex.org/W2059499441","https://openalex.org/W2059984016","https://openalex.org/W2060249257","https://openalex.org/W2061345986","https://openalex.org/W2070251374","https://openalex.org/W2071793852","https://openalex.org/W2081953717","https://openalex.org/W2093032646","https://openalex.org/W2095771928","https://openalex.org/W2097976367","https://openalex.org/W2099359513","https://openalex.org/W2100772783","https://openalex.org/W2103704392","https://openalex.org/W2108947370","https://openalex.org/W2112870272","https://openalex.org/W2113532957","https://openalex.org/W2116468415","https://openalex.org/W2116978122","https://openalex.org/W2117022661","https://openalex.org/W2118385988","https://openalex.org/W2120608237","https://openalex.org/W2127601862","https://openalex.org/W2131174104","https://openalex.org/W2131286882","https://openalex.org/W2134566943","https://openalex.org/W2138532022","https://openalex.org/W2138778824","https://openalex.org/W2142661339","https://openalex.org/W2143060756","https://openalex.org/W2158933399","https://openalex.org/W2160248511","https://openalex.org/W2161723491","https://openalex.org/W2166819037","https://openalex.org/W2992837203","https://openalex.org/W4236042930","https://openalex.org/W4238271314","https://openalex.org/W4256140460"],"related_works":["https://openalex.org/W2886943641","https://openalex.org/W2032044216","https://openalex.org/W3193682563","https://openalex.org/W2026521278","https://openalex.org/W2152265294","https://openalex.org/W2138061744","https://openalex.org/W2782458693","https://openalex.org/W2051776381","https://openalex.org/W2067168610","https://openalex.org/W1989116199"],"abstract_inverted_index":{"The":[0],"specificities":[1],"of":[2,28,36,54,84,102,156],"nine":[3],"approved":[4,113],"tyrosine":[5,38],"kinase":[6,22,60,89,114,138,157],"inhibitors":[7,86,115],"(imatinib,":[8],"dasatinib,":[9],"nilotinib,":[10],"gefitinib,":[11],"erlotinib,":[12],"lapatinib,":[13],"sorafenib,":[14],"sunitinib,":[15],"and":[16,46,80,105,143,154],"pazopanib)":[17],"were":[18,57,90,116],"determined":[19],"by":[20,59],"activity-based":[21],"profiling":[23,61,69,124,139],"using":[24],"a":[25,71],"large":[26],"panel":[27,34],"human":[29],"recombinant":[30],"active":[31],"kinases.":[32,50,122],"This":[33,108,123],"consisted":[35],"79":[37],"kinases,":[39,42,45],"199":[40],"serine/threonine":[41],"three":[43],"lipid":[44],"29":[47],"disease-relevant":[48],"mutant":[49],"Many":[51],"potential":[52],"targets":[53,153],"each":[55,88],"inhibitor":[56],"identified":[58],"at":[62,70,128,140],"the":[63,81,85,93,112,152],"K(m)":[64,142],"for":[65,119],"ATP.":[66],"In":[67],"addition,":[68],"physiological":[72,144],"ATP":[73,145],"concentration":[74,96],"(1":[75],"mm)":[76],"was":[77],"carried":[78],"out,":[79],"IC(50)":[82],"values":[83],"against":[87],"compared":[91],"with":[92],"estimated":[94],"plasma-free":[95],"(calculated":[97],"from":[98],"published":[99],"pharmacokinetic":[100],"parameters":[101],"plasma":[103],"C(trough)":[104],"C(max)":[106],"values).":[107],"analysis":[109],"revealed":[110],"that":[111],"well":[117],"optimized":[118],"their":[120],"target":[121],"also":[125],"implicates":[126],"activity":[127],"particular":[129],"off-target":[130],"kinases":[131],"in":[132,150],"drug":[133],"side":[134],"effects.":[135],"Thus,":[136],"large-scale":[137],"both":[141],"concentrations":[146],"could":[147],"be":[148],"useful":[149],"characterizing":[151],"off-targets":[155],"inhibitors.":[158]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1967676836","counts_by_year":[{"year":2026,"cited_by_count":10},{"year":2025,"cited_by_count":13},{"year":2024,"cited_by_count":15},{"year":2023,"cited_by_count":17},{"year":2022,"cited_by_count":14},{"year":2021,"cited_by_count":17},{"year":2020,"cited_by_count":21},{"year":2019,"cited_by_count":17},{"year":2018,"cited_by_count":17},{"year":2017,"cited_by_count":15},{"year":2016,"cited_by_count":24},{"year":2015,"cited_by_count":19},{"year":2014,"cited_by_count":21},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
